UBS Group’s Innovator US Equity Accelerated Plus ETF October XTOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-280
Closed -$9.13K 11260
2025
Q3
$9.13K Sell
280
-15
-5% -$481 ﹤0.01% 8620
2025
Q2
$9.24K Buy
295
+270
+1,080% +$7.85K ﹤0.01% 8900
2025
Q1
$713 Sell
25
-549
-96% -$16.2K ﹤0.01% 9679
2024
Q4
$16.9K Sell
574
-7,029
-92% -$206K ﹤0.01% 7989
2024
Q3
$219K Buy
7,603
+7,484
+6,289% +$213K ﹤0.01% 5805
2024
Q2
$3.37K Sell
119
-1,482
-93% -$41.4K ﹤0.01% 8226
2024
Q1
$44.4K Buy
1,601
+1,354
+548% +$36.8K ﹤0.01% 6565
2023
Q4
$6.57K Buy
+247
New +$6.28K ﹤0.01% 7692
2023
Q3
Sell
-1,711
Closed -$41.3K 10034
2023
Q2
$41.3K Buy
+1,711
New +$40.1K ﹤0.01% 6577
2022
Q3
Sell
-78
Closed -$2K 11012
2022
Q2
$2K Buy
78
+77
+7,700% +$1.78K ﹤0.01% 9631
2022
Q1
$0 Buy
+1
New +$25 ﹤0.01% 10992

Other funds holding XTOC

UBS Group's XTOC Position: Q4 2025 in Review

UBS Group sold out of Innovator US Equity Accelerated Plus ETF October (XTOC) in Q4 2025, closing a stake of 280 shares — an estimated $9.13K sold.

UBS Group first reported a position in XTOC in Q1 2022 and held it in 11 quarters. The position peaked at $219K in Q3 2024. 23 funds tracked by Wall St. Rank hold XTOC as of Q4 2025.

  • UBS Group reported no remaining Innovator US Equity Accelerated Plus ETF October position as of Q4 2025 after selling out during the quarter.
  • UBS Group sold 280 Innovator US Equity Accelerated Plus ETF October shares in Q4 2025, an estimated $9.13K.
  • UBS Group first reported a position in Innovator US Equity Accelerated Plus ETF October in Q1 2022 and held it in 11 quarters.
  • UBS Group's Innovator US Equity Accelerated Plus ETF October position peaked at $219K in Q3 2024.
  • 23 funds tracked by Wall St. Rank held Innovator US Equity Accelerated Plus ETF October as of Q4 2025.

Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.